Zobrazeno 1 - 10
of 1 316
pro vyhledávání: '"RM Califf"'
Publikováno v:
Europe PubMed Central
Publikováno v:
The Lancet. 359:1946
Autor:
Warraich HJ; US Food and Drug Administration, Silver Spring, Maryland., Tazbaz T; US Food and Drug Administration, Silver Spring, Maryland., Califf RM; US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA [JAMA] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.
Autor:
Warraich HJ; U.S. Food and Drug Administration, Silver Spring, Maryland (H.J.W., B.A.K., M.T.H., R.M.C.)., King BA; U.S. Food and Drug Administration, Silver Spring, Maryland (H.J.W., B.A.K., M.T.H., R.M.C.)., Compton WM; National Institutes of Health, Bethesda, Maryland (W.M.C., E.S.H., M.M.B.)., Herrmann ES; National Institutes of Health, Bethesda, Maryland (W.M.C., E.S.H., M.M.B.)., Hai MT; U.S. Food and Drug Administration, Silver Spring, Maryland (H.J.W., B.A.K., M.T.H., R.M.C.)., Califf RM; U.S. Food and Drug Administration, Silver Spring, Maryland (H.J.W., B.A.K., M.T.H., R.M.C.)., Bertagnolli MM; National Institutes of Health, Bethesda, Maryland (W.M.C., E.S.H., M.M.B.).
Publikováno v:
Annals of internal medicine [Ann Intern Med] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.
Autor:
Helms Williams EC; US Food and Drug Administration, Silver Spring, Maryland, USA. emily.helmswilliams@fda.hhs.gov., Bumpus NN; US Food and Drug Administration, Silver Spring, Maryland, USA., Califf RM; US Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Nature medicine [Nat Med] 2024 Sep 30. Date of Electronic Publication: 2024 Sep 30.
Autor:
Abbasi A; US Food and Drug Administration, Silver Spring, Maryland, USA., Rivera D; US Food and Drug Administration, Silver Spring, Maryland, USA., Curtis LH; US Food and Drug Administration, Silver Spring, Maryland, USA., Califf RM; US Food and Drug Administration, Silver Spring, Maryland, USA. commissioner@fda.hhs.gov.
Publikováno v:
Nature medicine [Nat Med] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.
Autor:
Abbasi AB; US Food and Drug Administration, Silver Spring, Maryland., Curtis LH; US Food and Drug Administration, Silver Spring, Maryland., Fleisher LA; University of Pennsylvania, Philadelphia., Califf RM; US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA [JAMA] 2024 Aug 06; Vol. 332 (5), pp. 412-417.
Autor:
Abbasi AB; US Food and Drug Administration, White Oak Campus, Silver Spring, Maryland., Curtis LH; US Food and Drug Administration, White Oak Campus, Silver Spring, Maryland., Califf RM; US Food and Drug Administration, White Oak Campus, Silver Spring, Maryland.
Publikováno v:
JAMA [JAMA] 2024 Jul 09; Vol. 332 (2), pp. 103-104.
Autor:
Angus DC; JAMA , Chicago, Illinois.; University of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pennsylvania., Huang AJ; University of California, San Francisco., Lewis RJ; JAMA , Chicago, Illinois.; David Geffen School of Medicine at UCLA, Los Angeles, California., Abernethy AP; Verily Life Sciences, San Francisco, California.; Now with Highlander Health, Dallas, Texas., Califf RM; US Food and Drug Administration, Washington, DC., Landray M; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.; Protas, Manchester, United Kingdom., Kass N; Johns Hopkins University, Baltimore, Maryland., Bibbins-Domingo K; JAMA , Chicago, Illinois.; University of California, San Francisco.
Publikováno v:
JAMA [JAMA] 2024 Jul 09; Vol. 332 (2), pp. 153-162.
Autor:
Warraich HJ; U.S. Food and Drug Administration, Silver Spring, Maryland, USA. Electronic address: haider.warraich@fda.hhs.gov., Califf RM; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Jul 02; Vol. 84 (1), pp. 124-129.